FDA Investigator Eileen J Bannerman

Eileen J Bannerman has inspections in 9 countries as of 27 Oct 2023. Eileen J Bannerman has collaborated with a combinined 3246 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
349
Last Inspection Date:
27 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
100005770
Country:
United Kingdom of Great Britain and Northern Ireland, United States of America, Germany, Spain, Italy, Israel, Canada, Romania
Co-Investigator(s):
A Williams, Aaron P Wozniak, Abdur Rashid, Adam J Williams, Adam R Cooke, Alia Legaux, Alphonso A Haupt, III, Amy A Johnson, Amy H Ruble, Andrea Lwilliams Jones, Angelica M Hernandez, Ann B Borromeo, Anthony J Grace, April R Bowen, Arlyss M Jones, Arthur G Hurst, Babatunde D Babalola, Barbara A Rusin, Barbara M Frazier, Betsy C Galliher, Billy M Battles, Bonita S Chester, Brandy D Brown, Brentley S Collins, Brian A Graves, Bridegan, Buford, Cara M Minelli, Carl E Lovrich, Carol J Blackwood, Carrie L Doupnik, CDR Thomas R Berry, PPh, Cheryl A Grandinetti, Cheryl D Barton, Cheryl Llove Harris, Chris Alexander, Christine M O'leary, Christopher J Adams, Christopher S Keating, Claudette D Brooks, Constance Y Fears, Contractor Bridgers, Cordelia J Brammer, Craig T Rybus, Cynthia F Kleppinger, MD, Cynthia Jim, CSO, Damon C Green, MD,MS, Daphne Santiago, PhD, David Williams, Davis, Dawn C Olenjack, Dawn M Braswell, Deborah A Greco, Debra J Tucker, Dellarese L Herbert, Dennis L Doupnik, Derek C Price, Devaughn Edwards, Deyaa Shaheen, Diane Hall, Doretha M Tonkins, Douglas L Page, Edward Deberry, Eileen J Bannerm, Eric S Weilage, Ernest H Blackwood, Esra Toussaint, Fabian Nchaparro Rodriguez, Frank W Perrella, Gabriel R Mclemore, Gamal A Norton, Garcia, Gary E Coleman, Jr, REHS, Gideon N Esuzor, Hai Lien Phung, Hai Lien T Phung, Harshal J Desai, Heather M Wheeler, Helen R Bester, Holly M Scott, Hristu B Chepa, Ibad U Khan, James R Betz, Janete F Guardia, Jared P Stevens, Jason F Chancey, Jason K Morgan, Jawaid Hamid, Jeff M Uriarte, Jennifer D Hollstrom, Jessica A Stephens, Joe A Odom, John D Lloyd, Johnson, Joseph F Owens, June P Page, Kara D Dobbin, Kara D Miller, Kassa Ayalew, MD, Kathleen D Culver, Kathryn Suttling, Kenneth L Smalls, Kimberly Cdelk Brooks, King, Kip J Hanks, Lareese K Thomas, Larry K Hampton, Lauren Ciacono Conners, Lauren Iacono Connors, PhD, Lauryl A Smith, Lawrence, Leon L Crawley, Lesley K Satterwhite, Leslie W Gilbert, Lillie D Witcher, Lisa P Oakes, LT Daveta L Bailey, Mancia R Walker, Marcella D Crook, Marie F Morin, Marla A Cassidy, Mary Alice Papdimitriou, Mary T Carden, Mathew T Thomas, MD, Megan T Ziegler, Metitia G Sanders, Metitia M Gramby, Miaja Umaedi, Michael M Quinn, Michelle D Haamid, Myckie M Jacobsen, Nancy E Fontaine, Navid R Homayouni, Nicholas M Smith, Nicole A Lloyd, Nicole M Bell, Nigel L Hirth, Pamela L Vega, Panney H Mccarver, Paul W Moy, Paula J Bretz, Penny H Mccarver, Perry H Gambrell, R Edwadebey Deberry, Rachael L Cook, Randy D Baxter, Randy L Clarida, Rashonda N Rucker, Reba A Gates, Rebecca Rodriguez, Regan T Harp, Richard J Bashay, Richard L Garcia, Robert C Coleman, Robert D Tollefsen, Robert W Turner, Robin N Goins, Rosia E Nesbitt, Russell R Zablan, Samantha J Bradley, Sandra I Gaul, Scott B Laufenberg, Scott T Ballard, Seneca D Toms, Sereen Gmorgan Murray, Sherri J Jackson, Smith, Sonya M Edmonds, State Agency, Steven M Weinman, Susan O Oladeji, Tajah L Blackburn, Tallman, Tamara M Casselman, Tamika D Cathey, Tawny L Colling, Theresa L Stewart, Thomas D Clarida, Thomas P Hansen, Tracy K Bell, Tracy L Ramseur, Tracy R Ball, Trang N Cox, Vanessa E Coulter, Veronica Fuentes, MS, Viviana Matta, Watson, William P Tonkins, Williams, Youmin Wang

Eileen J Bannerman's Documents

Publish Date Document Type Title
January, 2012 EIR Michael DeSantis - EIR, 2012-01-05
February, 2014 FDA 483 Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483, 2014-02-14
November, 2017 FDA 483 Hemanth Rao - Form 483, 2017-11-14
April, 2014 FDA 483 Alireza Nami MD - Form 483, 2014-04-15
July, 2015 EIR William Travis Ellison MD - EIR, 2015-07-01
February, 2014 EIR Generics Bidco II LLC d/b/a Prinston Laboratories - EIR, 2014-02-14
November, 2010 FDA 483 Mendolia, Thomas, DO - Form 483, 2010-11-01
December, 2004 FDA 483 Charles W. Lapp, M.D. - Form 483, 2004-12-13
August, 2013 FDA 483 Susan L. Stramer, Ph.D - Form 483, 2013-08-08
June, 2009 FDA 483 Marlin Company, Inc. - Form 483, 2009-06-11
April, 2015 EIR Cynthia B Strout, MD - EIR, 2015-04-30
September, 2014 EIR James Atkins - EIR, 2014-10-29
February, 2000 EIR Marc T. Silver, MD - EIR, 2000-02-01
May, 2009 FDA 483 PETNET SOLUTIONS, INC. - Form 483, 2009-05-06
September, 2004 EIR Gregory J. Feldman, M.D. - EIR, 2004-09-03
September, 2014 FDA 483 James Atkins - Form 483, 2014-09-25
April, 2014 EIR Alireza Nami MD - EIR, 2014-04-15
February, 2016 EIR PPD, Inc., part of Thermo Fisher Scientific - EIR, 2016-02-25
April, 2003 FDA 483 Christopher Phillips, CI - Form 483, 2003-04-03
August, 2018 FDA 483 Robert Clifford, M.D. - Form 483, 2018-08-22
September, 2004 FDA 483 Gregory J. Feldman, M.D. - Form 483, 2004-09-03
April, 2015 FDA 483 Cynthia B Strout, MD - Form 483, 2015-04-30
January, 2019 EIR IQVIA - EIR, 2019-01-30
February, 2013 EIR Wayne Memorial Hospital IRB - EIR, 2013-02-14
November, 2017 EIR Hemanth Rao - EIR, 2017-11-14
September, 2001 EIR Walter D. Holder, MD Clinical Investigator - EIR, 2001-09-06
February, 2003 EIR Laster, Andrew J. MD - EIR, 2003-02-20
April, 2018 FDA 483 Dr. Jason Burgess - Form 483, 2018-04-18
August, 2019 FDA 483 PPD, Inc., part of Thermo Fisher Scientific - Form 483, 2019-08-15
June, 2020 EIR Nigel S. Key, M.B., Ch.B., F.R.C.P. - EIR, 2020-06-04
February, 2001 FDA 483 Leiner Health Product, Llc - Form 483, 2001-02-01
September, 2001 FDA 483 Walter D. Holder, MD Clinical Investigator - Form 483, 2001-09-06
February, 2002 EIR Casat, Charles D., MD - Clinical Investigator - EIR, 2002-02-26
October, 2014 EIR Spartanburg Regional Health Services IRB - EIR, 2014-10-02
June, 2012 EIR Andrew Armstrong - EIR, 2012-06-15
March, 2007 FDA 483 Response Leiner Health Product, Llc - Form 483R, 2007-04-09
October, 2017 EIR ICON, Plc - EIR, 2017-10-27
June, 2002 EIR Charles Fogarty, M.D. - EIR, 2002-06-05
September, 2016 EIR Eva Heurich - EIR, 2016-09-30
July, 2018 FDA 483 Wake Forest University Health Sciences RDRC - Form 483, 2018-07-17
August, 2013 EIR Susan L. Stramer, Ph.D - EIR, 2013-08-08
March, 2007 FDA 483 Leiner Health Product, Llc - Form 483, 2007-03-16
October, 2000 FDA 483 American National Red Cross (The) Carolinas Region - Form 483, 2000-07-26
June, 2012 EIR Kimberly Blackwell, M.D. - EIR, 2012-06-07
January, 2003 EIR Atlas, Walter MD - EIR, 2003-01-15
February, 2014 FDA 483 Response Generics Bidco II LLC d/b/a Prinston Laboratories - Form 483R, 2014-05-15
February, 2013 FDA 483 Wayne Memorial Hospital IRB - Form 483, 2013-02-14
March, 2015 FDA 483 Albert Font - Form 483, 2015-03-06
August, 2002 FDA 483 American National Red Cross (The) Carolinas Region - Form 483, 2002-08-16
February, 2001 EIR Leiner Health Product, Llc - EIR, 2001-02-01
October, 2014 FDA 483 Spartanburg Regional Health Services IRB - Form 483, 2014-10-02
February, 2002 FDA 483 Dr. Charles D. Casat - Clinical Investigator - Form 483, 2002-02-26
August, 2008 EIR Baxter Healthcare Corporation - EIR, 2008-08-21
May, 2015 EIR Kathryn Lucas, M.D. - EIR, 2023-08-09
May, 2015 FDA 483 Kathryn Lucas, M.D. - Form 483, 2015-05-22

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more